Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2785–2808 of 26,682 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CTRL Clear all

Conditions: Postoperative Pain
Interventions: Ketamine, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Erythropoietic Protoporphyria (EPP)
Interventions: MT-7117 low dose, MT-7117 high dose, Placebo; Drug
Lead sponsor: Tanabe Pharma America, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 9
States / cities: Los Angeles, California • San Francisco, California • Miami, Florida + 6 more

Conditions: Mycobacterium Avium-intracellular Infection, HIV Infections
Interventions: Clarithromycin; Drug
Lead sponsor: Abbott; Industry
Eligibility: 12 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 1994
U.S. locations: 22
States / cities: Tucson, Arizona • Fresno, California • San Diego, California + 18 more

Conditions: Total Knee Arthroplasty
Interventions: Suzetrigine; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Obesity, Insulin Resistance, Inflammation
Interventions: Colchicine, Placebo; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 12 Years to 100 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)
Interventions: BI 770371, Placebo for BI 770371; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 13
States / cities: Chandler, Arizona • Coronado, California • Montclair, California + 8 more

Conditions: Aneuploidy, Genetic Counseling, Informed Consent, Decisional Conflict
Interventions: Video Educational Tool Regarding Prenatal Genetics; Other
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Measure Absorption of Vitamin D in Blood
Interventions: Vitafusion Extra Strength Vitamin D; Dietary Supplement
Lead sponsor: Church & Dwight Company, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Healthy
Interventions: Placebo, Dietary Supplement with actives; Dietary Supplement
Lead sponsor: Olly, PBC; Industry
Eligibility: 5 Years to 14 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Solid Tumor, Adult, Metastasis
Interventions: Palliative and Survivorship Care Model; Behavioral
Lead sponsor: Good Samaritan Hospital Medical Center, New York; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: West Islip, New York

Conditions: Chronic Rhinosinusitis (CRS), Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Interventions: OCEAN, Steroid-eluting sinus stent; Device
Lead sponsor: Polyganics BV; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 9
States / cities: Colorado Springs, Colorado • Atlanta, Georgia • Chicago, Illinois + 6 more

Conditions: ADHD
Interventions: Use of Noise Cancelling Headphones; Other
Lead sponsor: Duke University; Other
Eligibility: 6 Years to 17 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hiv, Sexual Health
Interventions: Parents and Adolescents Talking about Healthy Sexuality (PATHS), Lead with Love (LWL); Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 14 Years and older
Enrollment: 393 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Pressure Injuries, Pressure Ulcer Prevention
Interventions: A gamified mobile learning, Booklet training; Device · Other
Lead sponsor: Mehmet Akif Ersoy University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Contraceptive Usage, Contraceptive Behavior, Chronic Disease, Chronic Condition, Chronic Conditions, Multiple
Interventions: My Health, My Choice Web-Based Contraceptive Decision Tool, Usual Contraceptive Care; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 795 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 18
States / cities: Phoenix, Arizona • Pomona, California • Nampa, Idaho + 14 more

Conditions: Breast Cancer
Interventions: Elacestrant, Standard of Care; Drug
Lead sponsor: Stemline Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 478 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 104
States / cities: Tucson, Arizona • Jonesboro, Arkansas • Fullerton, California + 84 more

Conditions: Diabetic Foot
Interventions: GAM501, Placebo, Standard of care; Biological · Other
Lead sponsor: Tissue Repair Company; Industry
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 29
States / cities: Montgomery, Alabama • Mesa, Arizona • Phoenix, Arizona + 24 more

Conditions: Cardiovascular Disease
Interventions: Controlled diet with whole grain barley, whole grain oats, or low grain diet; Other
Lead sponsor: United States Department of Agriculture (USDA); Federal
Eligibility: 25 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Beltsville, Maryland

Conditions: Diabetes Mellitus, Type 2
Interventions: Placebo, Fasiglifam; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 421 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 55
States / cities: Dothan, Alabama • Muscle Shoals, Alabama • Goodyear, Arizona + 52 more

Conditions: Diffuse Large B-Cell Lymphoma
Interventions: bendamustine, navitoclax, rituximab; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 13
States / cities: Fountain Valley, California • Hudson, Florida • Lawrenceville, Georgia + 10 more

Conditions: Meniscus Tear
Interventions: AM3101, Saline Placebo; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 40 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Cincinnati, Ohio • Cleveland, Ohio • Portland, Oregon

Conditions: Ovarian Cancer
Interventions: oregovomab; Drug
Lead sponsor: Unither Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 62
States / cities: Huntsville, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 54 more

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: AST-120, Celphere CP-305; Drug
Lead sponsor: Ocera Therapeutics; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Restless Legs Syndrome (RLS)
Interventions: Injectafer, Placebo; Drug · Other
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 19
States / cities: Mobile, Alabama • National City, California • Rancho Mirage, California + 15 more

Search by objective public record fields.

Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

A Pilot Randomized Controlled Trial of Suzetrigine as an Adjunct to Multimodal Analgesia Following Total Knee Arthroplasty

Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity

A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

GEM: Impact of a Video Education Tool on Decisional Conflict Among Prenatal Patients

Bioequivalence Study on Vitamin D in Healthy Adults

A Clinical Study on the Effects of a Dietary Supplement on Stress, Anxiety, Mood and Sleep in a Pediatric Population

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)

Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD

Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents

Gamified Learning for Pressure Injury Prevention

A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions

Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities

Acute Heart Health Benefits of Whole Grain Barley and Oats in Healthy Men and Women

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

A Study of Navitoclax in Addition to Bendamustine and Rituximab in Patients With Relapsed Diffuse Large B-Cell Lymphoma (NAVIGATE)

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Clinical Trial for Ovarian Cancer (OvaRex®)

Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS